Your shopping cart is empty

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > Comparative Effectiveness Research Unlikely to Influence FDA, May Affect CMS, Expert Says

Drug Industry Daily

April 18, 2012 | Vol. 11 No. 77

Comparative Effectiveness Research Unlikely to Influence FDA, May Affect CMS, Expert Says

Drug sponsors may be able to relax a little about an upcoming jump in comparative effectiveness research (CER) and how it could affect FDA decisions.

This article is viewable by subscribers only. To view this article, please select an option below.

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.